Amarin Corp plc (ADR) (NASDAQ:AMRN)

Samuel Beckett Bridge

Are Biotech Stocks Located in Ireland Top Buyout Candidates?

St. Patrick's Day may have come and gone for this year, but some of the biotechnology stocks that are domiciled in Ireland might just be getting ready for the party. ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Amarin, Deere, First Solar and More

This week should be the end of the major earnings flood. With markets so close to highs, investors and traders alike are considering which stocks to buy and which ones ...
Read Full Story »
Pills

Amarin Implosion: The Future Went from Promising to Doubtful

Biotech is a sector where investors know they are entering a high-stakes game of big risk and big reward. That is particularly the case for the small-cap biotech stocks that ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Amarin, IBM, Salesforce.com, SolarCity and More

Earnings season has started as Washington, D.C., seems to have figured a way out of its shenanigans again. Now investors really have to be wondering which stocks to buy and ...
Read Full Story »
Food and Drug Administration logo

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

It looks like Congress and the president still cannot figure out how to play well with each other, and now we have another impending government shutdown. The reality is that ...
Read Full Story »
biotech

Top Biotech Stocks to Buy and Stocks to Short From PropThink

The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise, is the ...
Read Full Story »
Wall St Bull statue

12 Stocks Expected to Rise by 50% to 100% (or More) in 2013 (AMRN, CRZO, CNDO, EMKR, ETRM, EXAS, GALE, MX, OEDV, REGI, SPWR, SGYP)

It may seem hard to believe, but some stocks are expected to rise by 50%, 100%, or even more over the next year. Our own DJIA peak price target is ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — December 7, 2012: Markets Wobble to Mixed Close (TCK, MCD, SYT, AET, MPEL, HWD, PANW, SWHC, WGO, UEC, SMRT, SCHL, FGP, CMVT, AMRN, GRPN, F)

U.S. equity markets opened higher this morning following a poor growth forecast from Europe and a better-than-expected report on U.S. unemployment. The German central bank said this morning that Germany’s ...
Read Full Story »
pills

Amarin Takes on More Debt, Shares Suffer

Biopharmaceutical company Amarin Corp. PLC (NASDAQ: AMRN) announced after markets closed last night that it has received $100 million in nonequity financing from an investment fund managed by Pharmakon Advisors. ...
Read Full Story »

Top Analyst Upgrades and Downgrades (AMRN, BSX, BRCD, CVC, CFNL, CROX, FINL, FL, GMO, HMA, LAZ, NOV, OTEX, PCG, RH, SHOO, VPHM, YELP)

These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Tuesday. Amarin Corp. (NASDAQ: AMRN) started as Buy with $20 target at ...
Read Full Story »

Hot After-Hours Stocks on the Move (MDRX, AMRN, GRPN, KYAK, PCLN, EXPE,OWW, TRIP, LGF, MCP, PEGA, SPRD, ZIP)

We are tracking many key movers in the after-hours trading this Thursday. Most are earnings but some are not. Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) is up over 7% at $13.20 ...
Read Full Story »

Amarin Becomes A January 2013 Story on FDA Uncertainty

Amarin Corporation plc (NASDAQ: AMRN) is not exactly having a good day considering that its fish oil based drug for lowering triglycerides is not going to be a known event as soon ...
Read Full Story »

Amarin Shares Fall Despite Regulatory OK

Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp. (NASDAQ: AMRN) announced approval by the FDA for Vascepta to ...
Read Full Story »

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the ...
Read Full Story »

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in ...
Read Full Story »